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Endosomal-recycling centerInternalization of H-Ras from the cell surface onto endomembranes through vesicular endocytic pathways may
play a signiﬁcant role(s) in regulating the outcome of Ras signaling. However, the identity of Ras-associated
subcellular vesicles and the means by which Ras localize to these internal sites remain elusive. In this study, we
show that H-Ras is absent from endosomes initially derived from a clathrin-dependent endocytic pathway.
Instead, both oncogenic H-Ras-61L andwild type H-Ras (basal or EGF-stimulated) bind Arf6-associated clathrin-
independent endosomes and vesicles of the endosomal-recycling center (ERC). K-Ras4B-12V can also be
internalized via Arf6 endosomes, and the C-terminal tails of both H-Ras and K-Ras4B are sufﬁcient to mediate
localization of GFP chimeras to Arf6-associated vesicles. Interestingly, little Raf-1 was found on these Arf6-
associated endosomes evenwhen active H-Ras was present. Instead, endogenous Raf-1 distributed primarily on
EEA1-containing vesicles, suggesting that this H-Ras effector, although accessible for H-Ras interaction on the
plasma membrane, appears to separate from its regulator during early stages of endocytosis. The discrete and
dynamic distribution of Ras pathway components with spatio-temporal complexity may contribute to the
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Although the site of Ras signaling is widely depicted as the plasma
membrane, endocytosis of Ras pathway components is required to
achieve efﬁcient and speciﬁc spatio-temporal activation of downstream
cascades [1–3]. Ras proteins have now been shown to be distributed on,
and to produce signiﬁcant signals from, internal membranes [4–6]. The
means by which Ras proteins localize to these internal sites are varied
and complicated [7]. Some of these routesmay depend on release of Ras
from the plasma membrane, while others likely require transfer of
membrane tethered Ras between membranous compartments via
vesicular budding or fusion mechanisms. The classic vesicular internal-
ization route is via clathrin-mediated endocytosis. Formation of
clathrin-dependent trafﬁcmachineries requires involvement of clathrin
coat and adapter proteins, which are the key components of this
pathway. Although not as well characterized as clathrin-mediated
endocytosis, several pathways for clathrin-independent endosomal
entry of proteins have been described [8–13]. One of these is a pathwayidentiﬁable by the presence of the small GTPase Arf6 that participates in
vesicular trafﬁcking [14,15].
The internalization pathways of the H-Ras and K-Ras4B proteins
appear to differ. In neurons, calcium signals trigger Ca++/calmodulin
binding to K-Ras4B and cause the release of the K-Ras/calmodulin
complex from the plasma membrane [16]. This transient, cytosolic
complex is subsequently targeted to Golgi or recycling endosomes
[17]. Internalization of K-Ras can also be mediated through vesicular
endocytic pathways. Lu et al. [18] found K-Ras4B associated with
EEA1/Rab7-bearing early endosomes, as well as membranes of late
endosomes, lysosomes and multivesicular bodies in COS-1 cells.
For newly synthesized H-Ras, a small portion of the protein is
delivered to Golgi membranes, and from there, these molecules board
outward-bound exocytic vesicles [19,20]. However, the majority of
newly synthesized H-Ras appears to initially trafﬁc to the plasma
membrane via a non-conventional pathway that may be non-
vesicular in nature [21]. Additional studies indicate that palmitoylated
H-Ras that has already reached the plasma membrane can be de-
palmitoylated and released into the cytosol. The farnesylated but non-
acylated protein can then be re-palmitoylated, and thus captured on
internal membranes, to join with those H-Ras molecules traveling to
the plasma membrane via the biosynthetic vesicular pathway [20,22].
Like K-Ras, there is evidence that H-Ras can leave the plasma
membrane and enter vesicular endocytic pathways. H-Ras has been
repeatedly found on internal vesicles with all the characteristics of
endosomes [23–25]. A previous study has shown that both Rab5 and
Rab11 regulate translocation of H-Ras to the pericentriolar recycling
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sorting endosomes that are derived from both clathrin-mediated and
clathrin-independent pathways [11,26], thus, its presence does not
deﬁne a speciﬁc class of endosomes.
Several clues to the identity of H-Ras endocytic pathways have
been derived from the identiﬁcation of components from H-Ras
associated vesicles. One study demonstrated that H-Ras appears to be
present on endosomes containing epidermal growth factor receptor
(EGFR) [24]. Vesicles captured by magnetic beads coated with EGF
contained EGFR along with endogenous Ras isoforms. These endo-
some preparations also contained clathrin protein [27], suggesting
cargo, including Ras, on these captured vesicles may be derived from a
clathrin-dependent pathway. However, EGFR can be internalized via
both clathrin-dependent and independent mechanisms. Thus, the
identity and types of H-Ras associated vesicles remained undeﬁned.
Recently, Porat-Shliom et al. [28] has reported that endosomes in a
clathrin-independent pathway associated with Arf6 contained H-Ras.
They proposed an elegant model for sequential production of
phosphoinositides on these endosomes accompanied by signaling of
H-Ras to the phosphatidyl inositol 3-kinase (PI3-K) effector pathway.
However, this study did not, in a systematicway, rule out the possibility
that H-Ras can also enter cells via clathrin-mediated endocytosis.
Ras effector proteins can be internalized by clathrin-dependent
and clathrin-independent means. Effector components that are
involved in PI3-K signaling, as well as downstream components in
the Raf effector branch of the Ras pathway, including KSR1 and ERK,
have been found on clathrin-independent endosomes [28,29].
However, it is not clear if Raf-1 is also present on these vesicles, as
Raf-1 has been observed on early endosomes, co-localizing with the
EEA1 marker [25]. It has also been demonstrated that expression of
the constitutively active Rab5-Q79L protein causes some H-Ras, but,
notably, not Raf-1, to accumulate on enlarged endosomes [30]. Thus,
there is evidence that Raf-1 disengages from H-Ras associated
endosomes, and it has become important to test whether or not H-
Ras and Raf might be internalized together on newly generated
vesicles produced via clathrin-independent means.
Here, we characterize the endocytic itinerary of Ras, and
demonstrate that H-Ras is absent from clathrin-dependent endo-
somes and in particular, from EEA1-associated endosomes that harbor
Raf-1 proteins. Instead, we ﬁnd both H-Ras and K-Ras4B bind to Arf6-
associated vesicles and can be internalized by an Arf6 mediated,
clathrin-independent pathway. Although active H-Ras on these Arf6-
associated vesicles appears to signal to PI3-K, as previously suggested
by Porat-Shliom et al. [28], we found that these vesicles bound very
little Raf-1. Our studies suggest that co-localization with or disen-
gagement from different effectors at discrete subcellular locations
may provide a means for spatio-temporal regulation of Ras signaling
in cells.
2. Materials and methods
2.1. Plasmids, cell culture and DNA transfection
The H-Ras-WT, H-RasQ61L, and ExtRas cDNA plasmids in the
pcDNA3 vector were described previously [31]. Plasmids GFP-H-Ras-
WT, GFP-H-Ras-61L, GFP-K-Ras4B-12V, GFP-ExtRas-WT, and GFP-
ExtRas-61L were generated by PCR ampliﬁcation and cloned into the
pEGFP-C3 vector (Clontech Labs). The GFP-H-tail plasmid was
constructed by attaching the bases encoding the 10 C-terminal
amino acids of H-Ras (GCMSCKCVLS), a termination codon, and a
Bam H1 restriction enzyme site to pEGFP-C3 by PCR. We obtained the
following plasmids from Dr. J.G. Donaldson, National Institutes of
Health: Arf6-WT-GFP, Arf6-Q67L-GFP and GFP-K-tail (with the last 20
amino acids of K-Ras4B fused to the C-terminus of EGFP) in the
pEGFP-N1 vector; and Arf6-WT-HA, Arf6-Q67L-HA (with a C-terminal
hemagluttinin (HA) epitope tag) in the pXS vector.NIH 3T3 cells were cultured at 37 °C and 10% CO2 in Dulbecco's
modiﬁed Eagle's medium supplemented with 10% calf serum plus
penicillin, streptomycin, glutamine and sodium pyruvate. For immu-
noﬂuorescence and immuno-isolation, NIH 3T3 cells were transfected
with Effectene (Qiagen) and used after 24 hours or as mentioned in
the results. Stable lines contained H-Ras-61L or H-Ras-WT (pZIPneo
vector), or GFP-H-Ras-61L cDNA (pEGFP-C3 vector). Cells treatedwith
EGF (Gibco BRL) were cultured as described above but incubated with
5 or 10 ng/ml of EGF at 37 °C for the time as indicated, followed by
washing with phosphate-buffered saline and ﬁxation.
2.2. Antibodies
Primary antibodies used for immunoﬂuorescence included rat
monoclonal anti-Ras sc34 (Santa Cruz Biotechnology); the mouse
monoclonals anti-Ras 610010 (BD Bioscience; Fig. 4) and anti-Ras
LA069 (Quality Biotech); and the rabbit polyclonals anti-c-Raf-1 sc227
and anti-clathrin heavy chain sc9069 (Santa Cruz Biotechnology),
anti-EEA1 P1-063 (Afﬁnity BioReagents), anti-hemagluttinin
PRB101P (Convance) and anti-giantin PRB114C (Convance). Primary
antibodies used for immuno-isolation included mouse monoclonal
anti-Ras LA069 (Quality Biotech), rat monoclonal anti-Ras sc34 (Santa
Cruz Biotechnology), and rabbit polyclonals anti-EEA1 P1-063
(Afﬁnity BioReagents), and anti-hemagluttinin (HA) PRB101P (Con-
vance). Primary antibodies used for immunoblotting included mouse
monoclonals anti-Ras 610010 and anti-c-Raf 61051 (BD Biosciences),
anti-GFP 1814460 (Roche), and rabbit polyclonals anti-hemagluttinin
PRB101P (Convance) and anti-EEA1 P1-063 (Afﬁnity BioReagents).
Secondary antibodies from Molecular Probes included goat anti-
mouse IgG coupled to Alexa Fluor 350, goat anti-rat IgG coupled to
Alexa Fluor 488, and the Alexa Fluor 594 coupled goat anti-mouse IgG,
goat anti-rabbit IgG, and donkey anti-rat IgG.
2.3. Live cell labeling with transferrin antibody
To mark early endosomes of the clathrin-dependent pathway,
cells were transfected and incubated for 18 hours, then treated with
cycloheximide (10 μg/ml) for 5.25 hours, to allow time for previously
synthesized protein to vacate Golgi membranes. Cells were then chilled
for 45 minutes at 4 °C in medium containing 50 mM HEPES, pH 7.4
buffer, cycloheximide (10 μg/ml), and AlexaFluor 594 transferrin
T-13343 (Molecular Probes, 10 μg/ml). Finally, the cold medium was
removed and pre-warmed (37 °C) medium containing 50 mM HEPES,
pH 7.4was added and cells were incubated at 37 °C in awater bath for 1
minute before ﬁxation with cold 4% paraformaldehyde and processed
for immunoﬂuorescence. To mark the endosomal recycling center
(ERC), cells were transfected with various cDNAs, incubated for 18
hours, and then treated for 5.25 hours with cycloheximide (10 μg/ml).
AlexaFluor-transferrin T-13343 (Molecular Probes, 10 μg/ml) was
then added for 45 minutes. Cells were washed, ﬁxed and processed
for immunoﬂuorescence.
2.4. Immuno-isolation of EEA1 and Arf6 associated membranes
Twenty-four hours after transfection, cells were scraped into
300 μl of homogenization buffer (3 mM imidazole, pH 7.4, 1 mM
Na3VO4, 5 mM MgCl2, 1% Protease Inhibitor Cocktail (Sigma), and 5%
sucrose) and homogenized with 15 strokes in a Dounce homogenizer
followed by 20 passages through a 26-gauge needle. The nuclei and
unbroken cells were removed by centrifugation at 1300g (4 °C) for
10 minutes. This post-nuclear supernatant (PNS) was pre-cleared by
incubation for 1 hour at 4 °C with protein A (for rabbit anti-EEA1
antibody) or G (for mouse anti-HA to capture Arf6-Q67L-HA) agarose
beads (Invitrogen). The supernatant was incubated with rabbit EEA1
or mouse anti-HA antibody overnight for immunoprecipitation (IP).
The following day fresh protein A or G beadswere added for 2 hours at
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and boiled in SDS-PAGE sample buffer. Proteins associated with EEA1
or Arf6 coupled membranes were separated by SDS-PAGE and
detected on immunoblots with the indicated antibodies. Ninety-ﬁve
percent of the sample was loaded in the IP lane, and 5% in the PNS
lane. For control blot (Fig. 2E) supernant was incubated with rat anti-
H-Ras antibody.
2.5. Immunoblotting
Samples collected by immuno-isolation were separated by SDS-
PAGE. Proteins were transferred to polyvinylidene diﬂuoride (PVDF)
membranes (Pall Life Science). The PVDF membranes were incubated
in blocking buffer (Vector Labs 10× casein diluted to 1× in TTBS,
(0.15 mol/L NaCl, 0.05 mol/L Tris–HCl, 0.05% Tween-20, pH 7.4) for 20
minutes at room temperature, then washed in TTBS and incubated
with primary antibodies overnight at 4 °C. The proteins of interest
were detected using horseradish peroxidase-conjugated goat anti-
mouse or goat anti-rabbit secondary antibodies and an enhanced
chemiluminescence kit from Pierce.
2.6. Immunoﬂuorescence and preparation of sonicated membrane
fragments
NIH 3T3 cells were plated on coverslips coated with 100 μg/ml
poly-L-lysine (Sigma) and 500 μg/ml ﬁbronectin (Sigma) and trans-
fected with DNA. After 24 hours (or as mentioned in results), cells
were ﬁxed with fresh 4% formaldehyde in phosphate-buffered saline,
pH 7.4, at room temperature for 1 hour then permeabilized with
−20 °C methanol and quenched with 50 mM ammonium chloride in
phosphate-buffered saline. The ﬁxed cells were incubated with
blocking buffer (2% horse serum and 0.4% bovine serum albumin in
phosphate-buffered saline, pH 7.4) then sequentially with primary
and secondary antibodies diluted in blocking buffer. For the
experiment shown in Fig. 3D, cells were co-transfected with cDNAs
for H-Ras-61L and Arf6-Q67L-GFP. Cells were ﬁxed, and stained with
mouse anti-Ras (BD Bioscience 610010) and rabbit anti-Raf (Santa
Cruz Biotechnology sc227) antibodies. The Ras antibody was detected
with a goat anti-mouse IgG secondary antibody coupled to Alexa-
Fluor350 (blue), and its co-expression with Arf6 was visually
conﬁrmed, but blue images were not captured. To produce adherent
plasma membrane fragments, experiments were carried out as
described previously [32].
Processed coverslips were mounted in Vectashield mounting
medium (Vector Laboratories). All experimental ﬁndings reported
here are based on observations of more than 30 NIH3T3 cells (or 30
adherent membrane fragments) that showed co-expression of Ras,
Arf6, Raf-1 or markers described in the text. For experiments imaging
adherent membrane fragments, cells were analyzed using a 63× oil
immersion lens on a Nikon Eclipse E800 microscope with Spot RT
digital camera. All confocal images were taken with a Leica TCS-NT
confocal system with a 63× oil immersion lens with an aperture
adjustable from 1.32 to 0.6, using an argon laser (488 nm excitation)
and a krypton laser (568 nm excitation). Other images were taken
with Leica DMIRE2 microscope using a 100× oil immersion lens with
an aperture adjustable from 1.3 to 0.6 and Q Imaging Retiga 1300
camera. Images were exported to Adobe Photoshop 7.0 or, for the
images taken with the Leica DMIRE2 microscope; images were taken
in black and white, processed in Openlab3.5.1, displayed in colors and
then exported to Adobe Photoshop 7.0 to equalize image intensity
prior to merging. For some experiments, as indicated in the Figure
legends, a series of z-stack images were acquired using a motorized
stage on the Leica DMIRE2 microscope. These images were processed
using Openlab's nearest neighbor deconvolution module and pro-
cessed as above.3. Results
3.1. H-Ras does not bind endosomes of the clathrin-dependent pathway
Although numerous studies have demonstrated that H-Ras is
present on vesicles that harbor speciﬁc endosomal markers, the
endocytic itinerary of H-Ras has not been systemically characterized,
and the identity of vesicles that bind and internalize H-Ras, as well as
its effector Raf-1, remains uncertain.
Several reports have suggested that H-Ras might be internalized
on endosomes of the dynamin-sensitive, clathrin-dependent pathway
[24,27]. To test this idea, we used multiple methods to assess the
possible association of H-Ras with endosomes generated by the
clathrin-dependent pathway using NIH3T3 cells. In this pathway,
clathrin coat proteins are required for formation and budding of
endosomal vesicles from the plasma membrane, and detection of
these coat proteins has been used as an early marker of clathrin-
dependent endocytosis. In order to inspect speciﬁcally only plasma
membranes for possible H-Ras and clathrin co-localization, adherent
basal plasma membranes of transfected NIH 3T3 cells were prepared
by sonication, ﬁxed, and examined by indirect immunoﬂuorescence
[32]. At least 30 membrane sheets from cells transfected with either
the activated H-Ras-61L or H-Ras-WTwere assayed. However, neither
H-Ras-61L (Fig. 1A) nor H-Ras-WT (data not shown) overlapped with
clathrin heavy chain.
At a later step of the clathrin-dependent pathway, endosomes lose
their clathrin coats, but can bind the early endosome antigen-1 protein
(EEA1) [18]. Next, we testedwhetherH-Raswas present on these EEA1-
associated vesicles. On adherent fragments of basal membranes (N30
membrane sheets) fromsonicated cells, thepopulation of EEA1-positive
vesicles was clearly resolved, but again H-Ras (H-Ras-61L) was not
present on these vesicles (Fig. 1B). Furthermore, upon examination of
EEA1-positive vesicles in at least 30 intact cells, no overlap of H-Ras-WT
and EEA1was detected (Fig. 1C). These results indicated that neither an
oncogenic nor the normal form of H-Ras were present on early
endosomes derived from the clathrin-dependent pathway.
We also tested if H-Ras-WT that became transiently GTP-bound
after EGF stimulationmight now join the clathrin-dependent pathway
along with the EGF receptor [24]. This was a relevant question, as
the serum-activated form of cellular H-Ras is reported to shift from
raft-like lipid microdomains, to a more general membrane distribu-
tion from which clathrin-mediated internalization might occur [33].
However, after stimulation of cells for 10 minutes with a moderate,
10 ng/ml dose of EGF [34], no co-alignment of the EEA1 marker of
early endosomes and H-Ras-WT was detected (Fig. 1D) for N30 cells
examined.
As an additional test, a ﬂuorescent derivative of transferrin was
added to live cells to enable the ﬁrst minutes of clathrin-mediated
endocytosis to be tracked. Transferrin protein can localize to internal
vesicular compartments via the clathrin-dependent route [35]. For these
experiments, a 6-hour cycloheximide pre-treatment was included to
inhibit synthesis of protein and thereby to avoid imaging newly
synthesized H-Ras on Golgi-derived vesicles that might mingle with
the endocytic vesicles. Cells were then chilled and incubated with
transferrin, so as to label, but prevent internalization of, transferrin
receptors. Cells were warmed very brieﬂy (1 minute) to allow
internalization to re-start. Although H-Ras-positive vesicles were
present in the re-warmed cells, the transferrin-containing early
endosomes did not overlap with GFP-H-Ras-61L (Fig. 1E). Thus, for all
the cells we examined (N30), although H-Ras was present on internal
vesicles, it was notably absent from endosomes associated with these
characteristic steps of the clathrin-dependent endocytic route.
To supplement the imaging results presented above, we used a
biochemical approach to examine whether H-Ras in its GTP-bound
formmight be present on EEA1-containing endosomes. An antibody to
EEA1 was used to capture detergent-free membrane fragments and
Fig. 1. H-Ras is absent from endocytic vesicles of the clathrin-dependent pathway in
NIH 3T3 cells. Adherent membrane fragments from sonicated cells (A–B) allow
detection of nascent and newly emerged endosomes, while intact cells (C–E) provide
views of internalized vesicles. (A) A non-overlapping H-Ras-61L (green) and clathrin
heavy chain (red) localization pattern is apparent in this merged image of a plasma
membrane fragment. (B) The accumulation of EEA1 (red) is also distinct from that of
H-Ras-61L (green) on this membrane fragment and marks a later step in clathrin-
dependent vesicular maturation. (C) Discrete internalized vesicles are associated with
H-Ras-WT (green) or EEA1 (red) in quiescent cells and (D) in those stimulated with
EGF. (E) GFP-H-Ras-61L (green) and AlexaFluor-transferrin (red) are associated with
distinct vesicles in this merged image. Transferrin receptors internalize via clathrin-
coated vesicles. Vertical z-stack images of each color were deconvolved before merging.
Scale bars=5 μm. (F) H-Ras-61L was not detected on EEA1 associated vesicles.
Membranes from post-nuclear supernatant (PNS) of NIH 3T3 cells stably expressing
H-Ras-61L were captured with EEA1 antibody (IP). Proteins were separated by SDS-
PAGE and identiﬁed by immunoblotting with indicated antibodies. 95% of the sample
was loaded in the IP lane, and 5% in the PNS lane.
301J. McKay et al. / Biochimica et Biophysica Acta 1813 (2011) 298–307vesicles by immuno-isolation [25] and the presence of H-Ras and
endogenous Raf-1 on EEA1-containing endosomes was assessed. In
agreement with the previous imaging results, neither cellular H-Ras,
nor activated H-Ras-61L (Fig. 1F) could be detected on the captured
EEA1-containing membranes. Thus, by multiple techniques, we found
no evidence of H-Ras on newly generated endocytic vesicles that were
derived from the clathrin-dependent pathway. In spite of this absence,
endogenous Raf-1 was easily observed in these EEA1 antibody-
captured endosomes (Fig. 1F). This ability to capture a protein that
did associate with EEA1-containing membranes veriﬁed that the
membrane isolation protocol was successful, and validated the
absence of H-Ras on those membranes. This result also conﬁrmed
previous work that Raf-1 could be found on clathrin- and EEA1-
containing early endosomes [18,25,36]. All these studies indicated that
endosomes to which H-Ras was bound had not entered the cells via a
clathrin-mediated pathway.3.2. Endosomes associated with Arf6 bind H-Ras
A prominent class of non-clathrin plasma membrane structures in
ﬁbroblasts and endothelial cells is comprised of caveolae. However,
the ability of caveolae to internalize (as “caveosomes”) is generally
thought to be restricted to special situations, such as viral infection
[37,38]. H-Ras, although present on membranes with a low buoyant
density similar to that of caveolae, is largely absent from these
structures [32,33]. An additional type of clathrin-independent endo-
some is the type that arises from the Arf6-associated constitutive
pathway by which the endogenous major histocompatibility complex
I (MHC-I) is internalized [39]. Previously, it was reported using HeLa,
MCF7, HT1080 and COS-7 cells that H-Ras can bind these endosomes
and be internalized via this clathrin-independent pathway [28].
To determine if H-Ras is internalized via this pathway in our NIH3T3
cells, we co-transfected these cells with H-Ras-WT and a GFP-tagged
version of the cellular form of Arf6 (Arf6-WT-GFP). H-Ras-WT was
observed on the plasma membrane, as expected, and also on both small
endosomes and larger, apparentlyﬂuid-ﬁlled,macropinosomes thatwere
also populated by Arf6-WT-GFP (N30 co-transfected cells assayed,
Fig. 2A–A′). At high resolution (in a separate cell), the Arf6 and H-Ras
proteins appeared to inhabit adjacent but distinct domains of many of
these larger vesicles, producing a beaded appearance in cross-section
(Fig. 2B). For these resting NIH3T3 cells, WT H-Ras proteins were
predominantly in a GDP-bound state. Next, we tested the subcellular
localization of a constitutively active, GTP-bound H-Ras (H-Ras-61L) and
found that H-Ras-61L was also present on Arf6-associated endosomes
after its transient expression (N30 cells assayed, data not shown). These
results indicated that endosomes containing Arf6 could bind both wild
typeandoncogenicH-Ras, regardless of its activation state inNIH3T3cells,
and are similar to those foundbyPorat-Shliomet al. [28] usinghumanand
African green monkey cell lines. Together, these ﬁndings suggest that
Arf6-containing endosomes may be a type of trafﬁc machinery broadly
utilized for H-Ras internalization in mammalian cells.
Furthermore, we co-expressed the constitutively active, GTP-
bound form of Arf6 (Arf6-Q67L) with H-Ras-61L and assessed their
localization in cells. The inability of Arf6-Q67L to hydrolyze its bound
GTP prevents nascent endosomes from further progress, leading to an
endocytic cul-de-sac and the accumulation of cargo on multiple,
enlarged macropinosomes [28,40]. In cells that co-expressed Arf6-
Q67L-GFP and H-Ras-61L, the distinctive groups of these large, Arf6-
Q67L-GFP endosomal vesicles were brightly outlined by the H-Ras-
61L protein (N30 cells assayed, Fig. 2C–C").
These H-Ras containing vesicles were further characterized using a
biochemical approach. Cells were transfected with a hemagluttinin
(HA)-tagged Arf6-Q67L along with GFP-H-Ras-61L so that fragments of
Arf6-containing membranes could be immuno-isolated using HA
antibody. On these isolated, detergent-free fragments of Arf6-HA-
containing membranes, GFP-H-Ras-61L was present (Fig. 2D). A
reciprocal experiment, using H-Ras-directed antibody capture, showed
that Arf6-Q67L-GFP could also be detected on H-Ras-containing
membrane fragments (Fig. 2E). In addition, a control experiment, in
which anti-HA antibody-directed membrane isolation was performed
using cells that expressed only GFP-H-Ras, but had no Arf6-HA to
capture, showed that no GFP-H-Ras was present in the HA-antibody-
captured sample (Fig. 2F). This indicated that the presence of H-Ras in
the sample required Arf6, and was not the result of incomplete
membranewashingor non-speciﬁc bindingof H-Ras to theHA antibody.
3.3. Very little Raf-1 binds to H-Ras-61L on Arf6 endosomes
Previous studies demonstrated that clathrin-independent vesicles
harbor GTP-bound H-Ras [28]. Consistent with this ﬁnding, we also
detected active GTP-bound H-Ras on Arf6-associated endosomes
upon EGF stimulation (data not shown). This raised the question
whether Raf-1, which can bind GTP-bound H-Ras, might also be
Fig. 2. H-Ras is present on Arf6-associated vesicles in NIH 3T3 cells. Arf6 is often associated with small endosomes and larger, ﬂuid-ﬁlled macropinosomes [52]. Confocal images of a
cell expressing (A) H-Ras-WT (red) and (A′) Arf6-WT-GFP (green) proteins showing co-localization on small and large Arf6-WT-GFP associated vesicles. (B) Enlarged and merged
images of another cell showing the beaded appearance (arrows) of endosomal membranes with H-Ras-WT (red) and Arf6-WT-GFP (green) proteins bound. (C–C″) Confocal images
of a cell transfected with cDNAs encoding activated H-Ras-61L (red) and activated Arf6-Q67L-GFP (green) proteins. The merged image (C″) indicates Arf6-Q67L-GFP-associated
vesicles harbor H-Ras-61L proteins. Scale bars=5 μm. (D) Membrane fragments of NIH3T3 cells expressing GFP-H-Ras-61L and Arf6-Q67L-HA were prepared from post-nuclear
supernatant (PNS), and captured with anti-HA antibody (IP). Both Arf6-HA and GFP-H-Ras were present on these membranes and detected by immunoblotting using anti-HA (for
Arf6-HA) and anti-GFP (for GFP-H-Ras) antibodies. Asterisk (*) shows position of the HA-antibody heavy chain used for the immunoprecipitation. (E) NIH 3T3 cells stably expressing
H-Ras-61L were transfected with cDNA encoding Arf6-Q67L-GFP protein, membranes were prepared from the post-nuclear supernatant (PNS), and captured with anti-Ras antibody
(IP). Both H-Ras-61L and Arf6-Q67L-GFP proteins were detected using anti-Ras and anti-GFP antibodies, respectively. (C) Control experiment with anti-HA antibody isolation
performed on membrane fragments from the post-nuclear supernatant (PNS) of NIH 3T3 cells stably expressing GFP-H-Ras-61L proteins, without Arf6-Q67L-HA transfection (IP).
Although GFP-H-Ras-61L could be detected in the PNS, it was absent for the HA captured sample. Asterisk (*) shows the position of the HA-antibody heavy chain used for the
immunoprecipitation.
302 J. McKay et al. / Biochimica et Biophysica Acta 1813 (2011) 298–307present on Arf6-associated vesicles. Because Arf6 is present both on
the plasmamembrane (where Raf-1 is known to associate with active
H-Ras) as well as on endosomal membranes, immuno-isolation from a
mixture of plasma and endosomal membrane fragments could not
provide this answer; immunoﬂuorescence was used so that endo-
somes could be examined speciﬁcally. As observed in studies by Porat-
Shliom et al. [28] and this study (see Fig. 2C"), co-transfection of cells
with cDNAs for Arf6-Q67L and H-Ras-61L results in enlarged easily
identiﬁable endosomally derived vesicles. Next, we determined the
location of Raf-1 in such double-transfected NIH3T3 cells (N30 cell
assayed). Consistently, the characteristic Arf6-Q67L vesicles were
brightly rimmed with GFP-H-Ras-61L (Fig. 3A and B). However, the
Raf-1 antibody did not illuminate those clustered endosomes
(Fig. 3A′–B), and for this typical example, in only a few spots did
endogenous Raf-1 and H-Ras-61L co-localize on endosomes. As
expected, some endogenous Raf-1 did co-localize with H-Ras-61L at
the plasma membrane (Fig. 3C). A second experiment was performed
to directly examine whether smaller endosomes that displayed
transfected Arf6-Q67L-GFP and H-Ras-61L could bind Raf-1. Cells
that expressed exogenous H-Ras-61L and Arf6-Q67L-GFP on small
endosomes were identiﬁed (N30 cells assayed, see Materials and
methods). The staining for Raf-1 in these cells showed that very few of
the dots of endogenous Raf-1 aligned with the small Arf6-Q67L-GFP
endosomes, or with the clustered, larger, Arf6-Q67L-stimulated
endosomal structures (Fig. 3D). This further suggested that duringthe early stage of Arf6-Q67L-stimulated endocytosis, these Arf6
containing vesicles bound very little Raf-1, despite harboring
oncogenic H-Ras-61L proteins.
3.4. H-Ras is present in the perinuclear endosomal recycling center
Several studies suggest that Arf6-associated vesicles converge on
the endosomal recycling center (ERC) [39,41], where they mingle
among other endosomes that are derived, independently, from
clathrin-mediated endocytosis [35,42]. These Arf6-associated vesicles
can also participate in recycling to return proteins to the plasma
membrane [43,44]. Thus, the potential for an additional contribution
of endosomal pathways, and in particular the perinuclear endosomal
recycling center (ERC), to H-Ras localization was investigated.
Newly synthesized H-Ras has been found on Golgi membranes
[19]. In addition, other studies have demonstrated that H-Ras also
persists in the perinuclear area despite clearing the H-Ras biosyn-
thetic pathway through exposure of cells to cycloheximide [20,22,26].
In order to speciﬁcally distinguish the ERC from Golgi membranes,
transferrin, a protein known to enter the ERC area (via the clathrin-
mediated route), was used. In cells pre-treatedwith cycloheximide for
6 hours, live-cell uptake of AlexaFluor-transferrin for 45 minutes at
37 °C produced a strong perinuclear accumulation of transferrin in the
ERC, along with numerous peripheral transferrin-laden vesicles
traversing the cytoplasm. In these cycloheximide-treated cells (N30
Fig. 3. Very little Raf-1 is present on Arf6-containing endosomes. (A–C) NIH 3T3 cells were transfected with cDNAs for GFP-H-Ras-61L (green) and Arf6-Q67L-HA (unstained). Cells
were ﬁxed and stained with anti-Raf-1 antibody and AlexaFluor-labeled secondary antibody (red). Arrows in (A) indicate enlarged, Arf6-Q67L stimulated endosomal vesicles that
contain GFP-H-Ras-61L and chevrons in (A′) indicate the absence of endogenous Raf-1 on those vesicles. (B) Merged and enlarged boxed area of (A–A') with arrows indicating
enlarged endosomal vesicles that contain GFP-H-Ras-61L but lack Raf-1 proteins. (C) Merged images of H-Ras-61L (green) and endogenous Raf-1 (red) in a NIH 3T3 cell,
co-localization of H-Ras-61L and Raf-1 on plasmamembrane is indicted (arrow). (D)Merged images of Arf6-Q67L-GFP (green) and endogenous Raf-1 (red) in a NIH 3T3 cell that was
co-transfected with H-Ras-61L and Arf6-Q67L-GFP cDNAs. Arrow indicates an enlarged endosomal vesicle with Arf6-Q67L-GFP that lacks Raf-1; chevron indicates Raf-1 on a
separate structure that lacks Arf6. Scale bars=10 μm. Vertical z-stack images of each color were deconvolved and merged where indicated.
303J. McKay et al. / Biochimica et Biophysica Acta 1813 (2011) 298–307cells assayed), the previously synthesized H-Ras-61L that was located
on internal membranes co-localized entirely with the perinuclear
concentration of AlexaFluor-transferrin (Fig. 4A–A′), and not with a
marker of the cis-Golgi, giantin (Fig. 4B–C). Transfected H-Ras-WT
also co-aligned well with the transferrin-marked ERC (N30 cells
assayed, data not shown). This indicated that the internal membranes
populated by previously synthesized H-Ras were predominantly
those of the ERC, and that, with this protocol, very little H-Ras was
located or captured on Golgi membranes. This data complement the
report that H-Ras is associated with Rab11-positive vesicles in the
(pericentriolar) recycling center of CHO-K1 cells [26]. Notably, in
agreement with our ﬁndings described above for transfected cells, at
the periphery of cells that had not been transfected with Arf6 the
previously synthesized GFP-H-Ras-61L was present in small vesicles
that were separate from those that contained AlexaFluor-transferrin
(N30 cells assayed, Fig. 4D–E). Together, these results indicated that,
in addition to Arf6-associated endosomal membranes and mem-
branes of the Golgi, H-Ras could distribute in NIH3T3 cells to a third
location and type of internal membrane—the membranes of the ERC.
3.5. K-Ras4B can bind to Arf6 vesicles
The route of the outward, biosynthetic trafﬁcking of the non-
palmitoylated K-Ras4B protein is unknown, but appears to differ from
the vesicular mechanism used (occasionally) by H-Ras [21]. We
therefore examined if these two Ras proteins also differed in their
presence on Arf6-associated vesicles. In N30 transfected cells assayed,
activated GFP-K-Ras4B-12V protein could be clearly seen on the
plasma membrane (Fig. 5A) and on Arf6-Q67L-enlarged macropino-
somes (Fig. 5A′). This result indicated that Arf6-Q67L-associated
vesicles could also bind activated K-Ras4B, and that this form of Ras
was not excluded from these membranes.
The C-terminal tails of Ras proteins can guide their association
with cellular membranes. GFP chimeras of these tails have been
readily used as probes to track the subcellular location of Ras in
previous studies [17,47–49]. To further test our observation describedabove, we asked whether a GFP chimera having only the last twenty
C-terminal residues of K-Ras4B, GFP-K-tail, could mirror the ability of
the activated full-length K-Ras4B protein to bind Arf6-Q67L vesicles.
As they did with full length K-Ras protein, the Arf6-Q67L macropino-
somes bound this GFP-K-tail protein (N30 cells assayed, Fig. 5B). In a
parallel experiment, enlarged Arf6-Q67L associated vesicles also
bound a second chimeric version of GFP, GFP-H-tail, with the last
ten residues of H-Ras (N30 cells assayed, Fig. 5C).
Normal anchoring of K-Ras4B in the plasma membrane by its
C-terminal tail involves a strongly polybasic sequence that includes
six lysine residues, and an immediately adjoining farnesylated
terminal cysteine [17]. In contrast, H-Ras membrane targeting
depends on two neighboring cysteines that acquire palmitate groups
together with the farnesylated terminal cysteine [50]. To learn more
about the properties of these C-terminal residues in Arf6 vesicular
targeting, a chimeric H-Ras protein with C-terminal characteristics of
K-Ras4B (lysine residues) and H-Ras (palmitoylated residues) was
examined. This protein (ExtRas) associates with the plasma mem-
brane and becomes palmitoylated, but fails to undergo C-terminal
farnesylation and does not interact with ER or Golgi membranes
[31,46]. Interestingly, ExtRas differed from K-Ras4B and H-Ras, and
was not detected on Arf6-associated macropinosomes (N30 cells
assayed, Fig. 5D–D′). This was an important control because, although
endocytosis via Arf6-associated vesicles can occur continuously, Ras
protein binding to these endosomes was neither universal nor
inevitable.
4. Discussion
Ras small GTPases can reside on and signal from both the plasma
membrane and numerous types of endomembranes. Studies that seek
to reveal the identity of Ras-associated subcellular compartments, as
well as Ras trafﬁcking pathways can provide important insight to
understand the role(s) of spatio-temporal regulation on Ras signaling.
A previous study by Porat-Shliom et al. [28] elegantly showed that H-
Ras bound clathrin-independent, Arf6-associated vesicles in HeLa,
Fig. 4. H-Ras is present in the perinuclear endosomal-recycling center. (A–A′) Confocal
images of NIH 3T3 cells transfected with H-Ras-61L cDNA, treated with cycloheximide
for 6 hours, exposed to AlexaFluor-transferrin (red) for 45 minutes, then ﬁxed and
stained with H-Ras antibodies (green). Arrow (A) indicates perinuclear accumulation
of H-Ras-61L and arrowhead (A′) indicates transferrin. (B–C) Merged image of a cell
transfected with H-Ras-61L cDNA, treated with cycloheximide for 6 hours, ﬁxed, and
stained with antibodies for H-Ras (green) and giantin (red) with boxed area of
(B) enlarged in (C). Arrow denotes accumulated H-Ras-61L on perinuclear membranes
that do not contain giantin (arrowhead). (D) A cell treated as in (A–A') with boxed area
enlarged in (E) showing separate vesicles containing transferrin (red; arrowhead) and
H-Ras (green, arrow).
Fig. 5. K-Ras4B binds Arf6-associated vesicles. A confocal image of a NIH 3T3 cell
showing (A) GFP-K-Ras4B-12V (green; arrow) and (A′) Arf6-Q67L-HA (red; arrow-
head) proteins on enlarged macropinosomes. (B–C) C-terminal residues of K-Ras4B or
H-Ras can target GFP to enlarged Arf6 macropinosomes. (B) Localization of GFP-K-tail
(green) on Arf6-Q67L-HA (red) associated vesicles (arrow) is shown in a merged
image. (C) Merged images of a NIH 3T3 cell expressing GFP-H-tail (green) and Arf6-
Q67L-HA (red) proteins with arrow indicating co-localization. (D–D') Confocal images
indicate that (D) ExtRasWT (red) does not accumulate on (D') Arf6-WT-GFP enlarged
endosomal vesicles (green; arrowheads). Chevrons indicate absence of ExtRas on Arf6-
WT-coated vesicles. Vertical z-stack images of each color were deconvolved, and then
merged. Scale bars=10 μm.
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enter clathrin-dependent pathways was investigated using the
transferrin receptor as a marker. Here, we characterized the endocytic
itinerary of Ras in NIH3T3 cells using multiple, additional markers and
approaches to fully explore this possibility and found that from the
very earliest stages of endocytosis, H-Ras was absent from clathrin-
dependent endosomes.
Our study also provides evidence that in NIH3T3 ﬁbroblasts Arf6-
containing, clathrin-independent endosomes binds normal, growth
factor stimulated, and oncogenic forms of H-Ras. These vesicles are
separate from, and in addition to, exocytic vesicles of the H-Ras
biosynthetic pathway. Thus, an Arf6-associated means of H-Ras
endocytosis has been deﬁned in cell lines derived from at least three
different mammals and is likely a general means for H-Ras internali-
zation in higher organisms. Together, our results and those of Porat-
Shliom et al. [28] show that Arf6 endosomes provide a second,
membrane-basedmechanism for binding H-Ras to internal membranes
that is distinct from the deacylation-controlled cycle that shuttles H-Ras
between the cell surface, cytosol and internal membranes [5,20,22,51].
Several other clathrin-independent endocytic routes are rapidly beingdeﬁned [8,9,52–55]. Anothermember of theArf GTPase family, Arf1, has
recently been found to regulate a dynamin- and clathrin-independent
endocytic pathway [53]. However, this path is distinct from the Arf6
pathway, and does not appear to contain H-Ras [52]. It will now be
important to learn if H-Ras also utilizes other clathrin-independent
endosomes, or only those associated with Arf6.
Arf6 endosomes bind both inactive and active forms of H-Ras, and
thus provide a new platform for H-Ras signaling within the cell. The
nucleotide-independenceofH-Ras endosomebinding is consistentwith
previous reports and with the constitutive nature of Arf6-mediated
endocytosis [25,56–58]. Additionally, although Arf6 endocytosis occurs
305J. McKay et al. / Biochimica et Biophysica Acta 1813 (2011) 298–307continuously, it can also be regulated by other factors including the TBC
(Tre-2/Bub2/Cdc16) domain protein TRE17, the Arf6 nucleotide
exchange factor ARNO/cytohesin and the EFA6 family of Arf6 guanine
nucleotide exchange factors (GEFs) [56,59,60]. Internal localization of
H-Ras via deacylation/re-acylation also operates for bothGDP- andGTP-
bound forms [20,22]. Interestingly, palmitate turnover is accelerated
whenH-Ras is in theGTP-bound form [32], suggesting that the acylation
cycle of relocation may also be subject to control. While the plasma
membrane iswidely viewed as a static ﬁnal destination for Ras proteins,
this report adds support to the idea that the amount of Ras at the plasma
membrane (not just its activation state) may be dynamic and
continuously adjustable, by both deacylation and endocytosis.
This study also conﬁrms the presence of H-Ras in the perinuclear
recycling center as presented byGomez andDaniotti usingCHO-K1 cells
[26], and reveals an additional challenge for studies that wish to
measure H-Ras signaling from internal sites. Since the endocytic
recycling center is often embedded within or near the Golgi, it may be
necessary to distinguish H-Ras on ERC membranes from newly
synthesized or re-acylated H-Ras on Golgi membranes [22]. The
methods developed in this study may be useful for such studies.
Interestingly, we also found that K-Ras4B could bindArf6-associated
endosomes. In addition, Lu et al. [18] demonstrated that some K-Ras4B
co-localizes with clathrin- and EEA1/Rab5-bearing endosomes in EGF-
stimulated COS-1 cells. Thus, it seems K-Ras4B can be internalized
through both clathrin-dependent and independentmechanisms, and its
signalingmay be regulated not only qualitatively but also quantitatively
by endocytosis. It will be interesting to characterize howmuch K-Ras4B
is capable of entering cells via either of these pathways.
Since H-Ras on Arf6-associated vesicles can be transported to the
endosomal recycling center, we also tested whether K-Ras4B could
localize onto this perinuclear compartment. When the ERC was
marked by loading NIH3T3 cells with AlexaFluor-transferrin (without
Arf6-Q67L), activated K-Ras4B was not observed in the ERC (N30 cells
assayed, data not shown). Thus, in NIH3T3 cells, K-Ras4B differed
from H-Ras and did not bind either ERC or Golgi membranes. Gomez
and Daniotti [26] reported a similar result for K-Ras using CHO-K1
cells. However, in neurons stimulated with glutamate or the calcium
ionophore, ionomycin, both full-length K-Ras4B and a YFP-K-Ras-tail
construct have been observed on ERC and Golgi membranes [17,45].
Together, these results indicate that it will be important to further
study possible cell- and stimulus-speciﬁc variations in the internal-
ization of Ras proteins.
Thus, a dynamic view of Ras proteins emerge with their movement
to the plasma membrane from biosynthetic pathways, release and
return via constitutive endosomal pathways and in the case of acylated
Ras proteins (H-Ras, N-Ras and K-Ras-4A) membrane association
dependent on the acylation cycle. Upon activation by growth factors, a
new layer of dynamic complexity emerges with Ras interactions with
effector molecules at the plasmamembrane and those that occur or are
excluded from endocytic membranes.
4.1. Properties of Ras proteins that bind to Arf6-associated vesicles
Our results show that the seven, C-terminal residues of mature H-
Ras, with the accompanying farnesyl, methyl, and palmitoyl groups,
are sufﬁcient to induce endosome binding, just as they do for its
association with Golgi membranes [19,22]. Similarly, the C-terminal
tail of K-Ras4B can mediate localization to Arf6-associated endo-
somes. Since the GFP-H-tail protein resides in low-density (“raft”)
membrane microdomains [61], its internalization probably takes
place from these domains. The GFP-K-tail protein and the full-length
KRas4B-G12V protein, as well as GTP-bound forms of H-Ras, all of
which reside outside of the raft-like domains [47], were also observed
on Arf6-Q67L endosomal vesicles. These results are consistent with
reports that Arf6-associated endosomes can internalize proteins from
both types of domains [35,62]. The identiﬁcation of key C-terminalamino acid residues important for targeting H-Ras and K-Ras4B to
Arf6 vesicles remains a goal for future investigation.
4.2. The role of endosomes in H-Ras signaling
The separation of H-Ras from the clathrin-dependent pathway
has special importance for interactions between H-Ras and its effector,
Raf-1. Both in this work and in studies with insulin-stimulated [25],
angiotensin-stimulated [63], or EGF-stimulated cells [18], activated Raf-1
hasbeen foundprimarily onEEA1-containingendosomes. Thepresenceof
Raf-1onendosomesderived inpart fromtheclathrin-dependentpathway
is also consistent with the report that H-Ras-stimulated Raf-1 signaling is
decreased by down-regulation of clathrin-dependent endocytosis by a
dominant negative dynaminmutant [30]. Together, these reports suggest
that at least a portion of H-Ras-triggered, Raf-1 signals may occur on
classical early endosomes, without the presence of H-Ras. What prevents
Raf-1 from retaining its association with H-Ras as it leaves the plasma
membrane?ThispotentialdisengagementofRaf-1 fromactivatedH-Ras is
also consistentwith theﬁndings thatH-Ras:Raf interactions at the plasma
membrane are actually quite brief [64]. Future studies may help to link
endosomal trafﬁcking, H-Ras:effector interaction and the signaling output
of isoform speciﬁc Rasmediatedpathways. Since it appears that theH-Ras
and K-Ras4B proteins can utilize physically distinct endocytic routes, the
K-Ras4B that co-localizes with Raf-1 on endomembranes may have
preferential access to this effector pathway.
In contrast to the abundance of Raf-1 on classical early endosomes,
very little Raf-1 was found on Arf6-associated vesicles that contained
activated H-Ras-61L. Such a limitation in a major Ras effector pathway
suggests that the spectrum of signals arising from endosomal H-Ras
may differ from that of H-Ras on the plasma membrane. There is
already precedent for selective association of nucleotide exchange
factors (GEFs), effectors, and GTPase activating proteins (GAPs) with
H-Ras that is present on Golgimembranes [4,7,65]. Furthermore, Arf6-
associated endosomes bind other signaling proteins, such as Src and
Rac [35,59], which could inﬂuence or contribute to H-Ras signals that
might arise from endosomes.
4.3. Reciprocal interaction between Ras and Arf6
Ras signaling pathways have previously been linked functionally
with Arf6. Several studies show that Arf6 can activate members of the
Ras signaling pathway, the ERK and Akt protein kinases [28,29,66].
Reciprocally, H-Ras stimulates phosphatidylinositol 3-kinase activity,
which leads to membrane recruitment and activation of the Arf6
nucleotide exchange factor, ARNO [39]. Inhibition of the extracellular
signal-regulated kinases (ERKs) that are downstream of Ras proteins,
speciﬁcally impedes Arf6-mediated, but not clathrin-mediated,
endocytosis [29]. Arf6 and H-Ras collaborate in vesicular transport,
through co-stimulation of phospholipase D activity needed for vesicle
budding [67]. Both Arf6 and H-Ras proteins are also central to the
pinocytosis and membrane rufﬂing that are caused by growth factors.
The identiﬁcation of a speciﬁc class of endosomes towhichH-Ras can
bind in this and the study by Porat-Shliom et al. together with the
previous ﬁndings that H-Ras is found on recycling endosomes [26,28],
completes a framework for a new cycle by which membrane-bound H-
Ras trafﬁcs from plasma membrane, through internal sites, back to the
plasma membrane. These reports provide further pieces of the physical
foundation that will allow the reciprocal interactions of Arf6 and H-Ras,
and the impact of those interactions on signaling, to be unraveled.
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